Leelyn Smith’s VanEck Pharmaceutical ETF PPH Stock Holding History

Leelyn Smith’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-596	Closed	-$23.2K	–	338
2022 Q4	$23.2K	Buy	596 +298	+100%	+$22K	0.01%	240
2022 Q3	$20K	Hold	298	–	–	0.01%	230
2022 Q2	$23K	Sell	298 -160	-35%	-$12.5K	0.01%	237
2022 Q1	$37K	Hold	458	–	–	0.01%	209
2021 Q4	$35K	Hold	458	–	–	0.01%	217
2021 Q3	$33K	Hold	458	–	–	0.01%	212
2021 Q2	$33K	Hold	458	–	–	0.01%	211
2021 Q1	$32K	Hold	458	–	–	0.01%	219
2020 Q4	$30K	Buy	458 +53	+13%	+$3.4K	0.01%	216
2020 Q3	$25K	Buy	405 +160	+65%	+$10.1K	0.01%	217
2020 Q2	$15K	Hold	245	–	–	0.01%	287
2020 Q1	$13K	Hold	245	–	–	0.01%	227
2019 Q4	$16	Buy	+245	New	+$14.8K	0.01%	238

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

VAS

Valicenti Advisory Services Elmira, New York $530M AUM 46.5% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return

Leelyn Smith's PPH Position: Q1 2023 in Review

Leelyn Smith sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2023, closing a stake of 596 shares — an estimated $23.2K sold.

Leelyn Smith first reported a position in PPH in Q4 2019 and held it in 13 quarters. The position peaked at $37K in Q1 2022. 106 funds tracked by Wall St. Rank hold PPH as of Q1 2023.

Leelyn Smith reported no remaining VanEck Pharmaceutical ETF position as of Q1 2023 after selling out during the quarter.
Leelyn Smith sold 596 VanEck Pharmaceutical ETF shares in Q1 2023, an estimated $23.2K.
Leelyn Smith first reported a position in VanEck Pharmaceutical ETF in Q4 2019 and held it in 13 quarters.
Leelyn Smith's VanEck Pharmaceutical ETF position peaked at $37K in Q1 2022.
106 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2023.

Based on Leelyn Smith's 13F filing for Q1 2023, filed 12 May 2023.